AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CVS HEALTH Corp Director's Dealing 2017

Aug 18, 2017

29875_dirs_2017-08-18_dc1389fd-3612-4580-9ee2-dc45dc643693.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CVS HEALTH Corp (CVS)
CIK: 0000064803
Period of Report: 2017-08-16

Reporting Person: SWIFT RICHARD J (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-08-16	Common Stock	S	2500	$79.62	Disposed	3258	Direct

Footnotes

F1: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $79.54 and $79.66 per share.